Yifan Pharmaceutical (002019.SZ) subsidiary obtains two drug registration certificates.

Zhitan Financial News App News, Yifan Medicine (002019.SZ) announced that its wholly-owned subsidiary, Hefei Yifan Biopharmaceutical Co., Ltd., received the Injection Drug Registration Certificate for Hydrochloride Betamethasone and Azacitidine issued by the National Medical Products Administration on June 4, 2025.